Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin extended-release tablets for painful diabetic peripheral neuropathy
CTR20232634Phase 3Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in diabetic polyneuropathy (DPN), sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20232634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232634.